Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients

EBioMedicine

Volumn 10, Issue , 2016, Pages 305-311

  Bartolucci, Pablo ^a   Habibi, Anoosha ^a   Khellaf, Mehdi ^a   Roudot Thoraval, Françoise ^a   Melica, Giovanna ^a   Lascaux, Anne Sophie ^a   Moutereau, Stéphane ^a   Loric, Sylvain ^a   Wagner Ballon, Orianne ^a   Berkenou, Jugurtha ^a   Santin, Aline ^a   Michel, Marc ^a   Renaud, Bertrand ^a   Lévy, Yves ^a   Galactéros, Frédéric ^a   Godeau, Bertrand ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Acute chest syndrome; Prospective study; Score; Sickle cell disease; Vaso occlusive crisis

Indexed keywords

MORPHINE;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; BLOOD TRANSFUSION; BLOOD VESSEL OCCLUSION; DRUG USE; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETICULOCYTE COUNT; SCORING SYSTEM; SICKLE CELL ANEMIA; ANEMIA, SICKLE CELL; BLOOD; COMORBIDITY; COMPLICATION; HOSPITAL ADMISSION; HOSPITAL EMERGENCY SERVICE; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; THORAX PAIN; THORAX RADIOGRAPHY; YOUNG ADULT;

ACUTE CHEST SYNDROME; ADULT; ANEMIA, SICKLE CELL; CHEST PAIN; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; PROGNOSIS; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 85027935937     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.06.038     Document Type: Article

References (31)

1. Ballas, S.K., Lusardi, M., Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am. J. Hematol. 79:1 (2005), 17–25.
2. Ballas, S.K., Larner, J., Smith, E.D., Surrey, S., Schwartz, E., Rappaport, E.F., Rheologic predictors of the severity of the painful sickle cell crisis. Blood 72:4 (1988), 1216–1223.
3. Bartolucci, P., El Murr, T., Roudot-Thoraval, F., et al. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood 114:18 (2009), 3742–3747.
4. Bartolucci, P., Chaar, V., Picot, J., et al. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation. Blood 116:12 (2010), 2152–2159.
5. Belcher, J.D., Marker, P.H., Weber, J.P., Hebbel, R.P., Vercellotti, G.M., Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96:7 (2000), 2451–2459.
6. Bernini, J.C., Rogers, Z.R., Sandler, E.S., Reisch, J.S., Quinn, C.T., Buchanan, G.R., Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 92:9 (1998), 3082–3089.
7. Browne, P.V., Hebbel, R.P., CD36-positive stress reticulocytosis in sickle cell anemia. J. Lab. Clin. Med. 127:4 (1996), 340–347.
8. Buchanan, I.D., Woodward, M., Reed, G.W., Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome. Pediatr. Blood Cancer 45:5 (2005), 716–724.
9. Cartron, J.P., Elion, J., Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfus. Clin. Biol. J. Soc. Fr. Transfus. Sanguine 15:1–2 (2008), 39–50.
10. Castro, O., Brambilla, D.J., Thorington, B., et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 84:2 (1994), 643–649.
11. Chaar, V., Picot, J., Renaud, O., et al. Aggregation of mononuclear and red blood cells through an α4β1-Lu/basal cell adhesion molecule interaction in sickle cell disease. Haematologica 95:11 (2010), 1841–1848.
12. Charache, S., Dover, G.J., Moore, R.D., et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:10 (1992), 2555–2565.
13. Charache, S., Terrin, M.L., Moore, R.D., et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N. Engl. J. Med. 332:20 (1995), 1317–1322.
14. El Nemer, W., Gane, P., Colin, Y., et al. The Lutheran blood group glycoproteins, the erythroid receptors for laminin, are adhesion molecules. J. Biol. Chem. 273:27 (1998), 16686–16693.
15. Gladwin, M.T., Kato, G.J., Weiner, D., et al. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 305:9 (2011), 893–902.
16. Hamideh, D., Alvarez, O., Sickle cell disease related mortality in the United States (1999–2009). Pediatr. Blood Cancer 60:9 (2013), 1482–1486.
17. Hebbel, R.P., Adhesive interactions of sickle erythrocytes with endothelium. J. Clin. Invest. 100:11 Suppl. (1997), S83–S86.
18. Hidalgo, A., Chang, J., Jang, J.E., Peired, A.J., Chiang, E.Y., Frenette, P.S., Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat. Med. 15:4 (2009), 384–391.
19. Joneckis, C.C., Ackley, R.L., Orringer, E.P., Wayner, E.A., Parise, L.V., Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 82:12 (1993), 3548–3555.
20. Kopecky, E.A., Jacobson, S., Joshi, P., Koren, G., Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease. Clin. Pharmacol. Ther. 75:3 (2004), 140–146.
21. Limbird, L.E., Gill, D.M., Stadel, J.M., Hickey, A.R., Lefkowitz, R.J., Loss of beta-adrenergic receptor-guanine nucleotide regulatory protein interactions accompanies decline in catecholamine responsiveness of adenylate cyclase in maturing rat erythrocytes. J. Biol. Chem. 255:5 (1980), 1854–1861.
22. Lionnet, F., Arlet, J.B., Bartolucci, P., Habibi, A., Ribeil, J.A., Stankovic, K., Guidelines for management of adult sickle cell disease. La Rev. Med. Interne 30:Suppl. 3 (2009), S162–S223.
23. Maitre, B., Habibi, A., Roudot-Thoraval, F., et al. Acute chest syndrome in adults with sickle cell disease. Chest 117:5 (2000), 1386–1392.
24. Mekontso Dessap, A., Leon, R., Habibi, A., et al. Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease. Am. J. Respir. Crit. Care Med. 177:6 (2008), 646–653.
25. Murray, N., May, A., Painful crises in sickle cell disease—patients' perspectives. BMJ 297:6646 (1988), 452–454.
26. Orringer, E.P., Casella, J.F., Ataga, K.I., et al. Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial. JAMA 286:17 (2001), 2099–2106.
27. Perronne, V., Roberts-Harewood, M., Bachir, D., et al. Patterns of mortality in sickle cell disease in adults in France and England. Hematol. J. Off. J. Eur. Haematol. Assoc./EHA 3:1 (2002), 56–60.
28. Platt, O.S., Brambilla, D.J., Rosse, W.F., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330:23 (1994), 1639–1644.
29. Swerlick, R.A., Eckman, J.R., Kumar, A., Jeitler, M., Wick, T.M., Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 82:6 (1993), 1891–1899.
30. Turhan, A., Weiss, L.A., Mohandas, N., Coller, B.S., Frenette, P.S., Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc. Natl. Acad. Sci. U. S. A. 99:5 (2002), 3047–3051.
31. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N. Engl. J. Med. 342:25 (2000), 1855–1865.